Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 510

1.
2.

Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?

Moro E, Alessandrini P, Zambon C, Pianetti S, Pais M, Cazzolato G, Bon GB.

Diabet Med. 1999 Aug;16(8):663-9.

PMID:
10477211
5.

Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus.

Anderson JW, Gowri MS, Turner J, Nichols L, Diwadkar VA, Chow CK, Oeltgen PR.

J Am Coll Nutr. 1999 Oct;18(5):451-61.

PMID:
10511327
7.

Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.

Cusi K, Cunningham GR, Comstock JP.

Diabetes Care. 1995 Jun;18(6):843-51.

PMID:
7555511
8.
9.

Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes.

Pedersen H, Petersen M, Major-Pedersen A, Jensen T, Nielsen NS, Lauridsen ST, Marckmann P.

Eur J Clin Nutr. 2003 May;57(5):713-20.

PMID:
12771973
10.
11.

E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress.

Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V.

Diabetologia. 1997 May;40(5):584-9.

PMID:
9165228
12.
13.

Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes.

Astley S, Langrish-Smith A, Southon S, Sampson M.

Diabetes Care. 1999 Oct;22(10):1626-31.

14.

Oxidant and antioxidant systems in niddm patients: influence of vitamin E supplementation.

Gökkusu C, Palanduz S, Ademoğlu E, Tamer S.

Endocr Res. 2001 Aug;27(3):377-86.

PMID:
11678585
15.
16.

In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes.

Jenkins AJ, Thorpe SR, Alderson NL, Hermayer KL, Lyons TJ, King LP, Chassereau CN, Klein RL.

Metabolism. 2004 Aug;53(8):969-76.

PMID:
15281003
17.
18.
19.

Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?

Romano G, Patti L, Innelli F, Di Marino L, Annuzzi G, Iavicoli M, Coronel GA, Riccardi G, Rivellese AA.

Diabetes. 1997 Oct;46(10):1601-6.

PMID:
9313756
20.

Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.

Diabetes Metab. 2000 Nov;26(5):387-92.

PMID:
11119018

Supplemental Content

Support Center